Abstract

Neuropati merupakan salah satu komplikasi tersering pada diabetes melitus (DM). Neuropati dapat memengaruhi kualitas hidup, derajat kesehatan, maupun tingkat ekonomi. Oleh karena itu, penting untuk mengetahui kualitas hidup pasien DM dengan neuropati beserta dampak yang ditimbulkannya terlebih dahulu agar mendapatkan penanganan yang tepat demi meningkatkan kualitas hidup pasien. Penelitian ini bertujuan untuk mengetahui profil kualitas hidup pasien DM dengan neuropati. Penelitian ini merupakan studi observasional menggunakan Short Form 8 (SF-8) Health Survey Standard Indonesia terhadap pasien diabetes melitus dengan neuropati yang diambil secara konsekutif pada bulan Maret hingga Agustus 2016 di Poli Saraf Rumah Sakit Bethesda, Yogyakarta. Terdapat 57 subjek yang dimasukkan dalam penelitian ini. Sebanyak 52,6 % di antaranya adalah perempuan dengan rerata usia 57,3 ±5,85 tahun. Skor kualitas hidup pasien neuropati DM yang paling rendah terdapat pada kategori kesehatan umum (45,26%) disusul nyeri pada tubuh (57,19%), vitalitas atau energi (69,12%), fungsi fisik (69,82%), fungsi sosial (74,03%), kesehatan mental (78,59%), kemampuan peran dengan masalah kesehatan fisik (80,70%), dan kemampuan peran dengan masalah emosi (81,05%). Jenis kelamin dan usia tidak berhubungan secara signifikan terhadap kualitas hidup pasien DM dengan neuropati. Neuropathy is one of the most common complications in patients with diabetes mellitus (DM). Neuropathy has contributed to some impacts of quality of life (QOL), general health status, and socio-economy level. Therefore, it is important to understand more about this issue, so appropriate treatment could be taken to improve QOL of patients with diabetic neuropathy. This study aimed to measure the profile of a patient’s life quality in DM with neuropathy. This study was a observational study using Short Form 8 (SF-8) Health Survey Standard Indonesia to measure the QOL in patients with diabetic neuropathy that were treated consecutively from March to August 2016 in the Department of Neurology in Bethesda Hospital, Yogyakarta. Fifty seven patients with diabetic neuropathy were enrolled as subjects in this study. Most of them were women (52,6%). The mean age of subjects was 57.3 ± 5.85 years. The lowest QOL score in patients with diabetic neuropathy were observed in general health perceptions category (45.26%), followed by bodily pain (57.19%), vitality or energy (69.12%), physical functioning (69.82%), social role functioning (74.03%), mental health (78.59%), physical role functioning (80.70%), and emotional role functioning (81.05%). Patients with diabetic neuropathy have poor QOL. Sex and age were not significantly related to the QOL in patients with diabetic neuropathy.

References

1. Dobrota VD, Hrabac P, Skegro D, Smiljanic R, Dobrota S, Prkacin I, et al. The impact of neuropathic pain and other comorbidities on the QOL in patients with diabetes. Health and QOL Outcomes. 2014; 12: 171.

2. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. 2013 [cited 2016 Sept 23]. Available from: www.diabetesatlas.org.

3. Rajan RS, de Gray L, George E. Painful diabetic neuropathy. Continuing education in anaesthesia, critical care and pain. Revalidation for Anaesthetists. 2013; 14: 230-5.

4. Kementrian Kesehatan Republik Indonesia. INFODATIN. Pusat Data dan Informasi Kementerian Kesehatan Republik Indonesia. Situasi dan Analisis Diabetes. 2014 [cited 2016 Sept 26]. Available from: http://www.depkes.go.id

5. Bansal V, Kalita J, Misra UK. Diabetic neuropathy. Postgraduate Medical Journal. 2006; 82: 95-100.

6. Kulkantrakom K, Lorsuwansiri C. Sensory profile and its impact on QOL in patients with painful diabetic polyneuropathy. Journal of the Neurological Sciences. 2013; 333(496): 519-36.

7. Tsuji M, Yasuda T, Kaneto H, Matsuoka T, Hirose T, Kawamori R. Painful diabetic neuropathy in Japanese diabetic patients is common but underrecognized. Pain Study and Treatment. 2013; 2013: 318352.

8. Smith SC, Lamping DL, Maclaine GDH. Measuring health-related QOL in diabetic peripheral neuropath: a systematic review. Diabetes Study and Clinical Practice. 2012; 96: 261-70.

9. Roberts B, Browne J, Ocaka KF, Oyok T, Sondorp E. The realibility and validity of the SF-8 with a conflict-affected population in northern Uganda. Health and QOL Outcomes. 2008; 6:108.

10. Lefante JF, Harmon GN, Ashby KM, Bernard D, Webber LS. Use of the SF-8 to assess health related QOL for a chronically ill, low income population participating in the Central Louisiana Medication Assess Program (CMAP). QOL Study. 2005; 14: 665-73

11. Tokuda Y, Okubo T, Ohde S, Jacobs J, Takahashi O, Omata F, et al. Assessing items on the SF-8 Japanese version for health-related QOL: a psychometric analysis based on the nominal categories model of item response theory. Value in Health. 2009; 12(4): 569-73.

12. Abbott CA, Malik RA, van Ross E, Kulkarni J, Boulton AJM. Prevalence and characteristics of painful diabetic neuropathy in a large comunitybased diabetic population in the UK. Diabetes Care. 2011; 34: 2220-4.

13. Cheah WL, Lee PY, Lim PY, Fatin Nabila AA, Luk KJ, Nur Irwana AT. Perception of QOL among people with diabetes. Malaysian Family Physician. 2012; 7(2&3): 21-30.

14. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006; 29(7): 1518-22.

15. Morkrid K, Ali L, Hussain A. Risk factors and prevalence of diabetic peripheral neuropathy: a study of type 2 diabetic outpatients in Bangladesh. International Journal of Diabetes in Developing Countries. 2010; 30(1): 11-7.

16. Boru UT, Alp R, Sargin H, Kocer A, Sargin M, Luleci A, et al. Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey. Endocrine Journal. 2004; 51(4): 563-7.

17. Rosyada A, Trihandini I. Determinan of DM chronic complications on elderly. Kesmas: National Public Health Journal. 2013; 7(9): 395-401.

18. Boyd A, Casselini C, Vinik E, Vinik A. QOL and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate. Journal of Diabetes Science and Technology. 2011; 5(3): 714-22.

19. Olmez N, Degirmenci Y, Kececi H. Effects of pain and disability on QOL. Neuroscience & Medicine. 2015: 6: 98-106.

20. Chiles NS, Phillips CL, Volpato S, Bandinelli S, Ferrucci L, Guralnik JM, et al. Diabetes, peripheral neuropathy, and lower extremity function. Journal of Diabetes and Its Complications. 2014; 28(1): 91-5.

Download

Share

COinS